CoagulationDisorders near Jamaica, NY
We found 1,101 results within 10 miles for "CoagulationDisorders near Jamaica, NY"

- Appt. wasn't rushed (4)

- Appt. wasn't rushed (4)
- Offers Telehealth

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Joshua Brody, MD is an Oncology Specialist who practices in New York, NY. He is 51 years old and has been practicing for 25 years. Dr. Joshua Brody, MD is affiliated with Mount Sinai Hospital.

- Appt. wasn't rushed (12)
- Listened/answered questions (12)
- Explains conditions well (12)
- View 1 more provider attributes

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Keren Osman, MD is an Oncology Specialist who practices in New York, NY. She is 55 years old and has been practicing for 29 years. Dr. Keren Osman, MD is affiliated with Mount Sinai Hospital.

- Felt Respected (1)

- Explains conditions well (29)
- Appt. wasn't rushed (28)
- Found trustworthy (28)
- View 2 more provider attributes
- Offers Telehealth

- Felt Respected (1)
- Offers Telehealth


- Offers Telehealth
Biography: Dr. Sofya Pintova, MD is a Hematology Specialist who practices in Brooklyn, NY. She is 43 years old and has been practicing for 17 years. Dr. Sofya Pintova, MD is affiliated with Mount Sinai Morningside, Mount Sinai Hospital and Mount Sinai Brooklyn.

- Found trustworthy (67)
- Explains conditions well (66)
- Listened/answered questions (65)
- View 1 more provider attributes

- Offers Telehealth

- Listened/answered questions (17)
- Explains conditions well (17)
- Found trustworthy (17)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: I have always been exquisitely sensitive to the cultural and emotional aspects of being ill. Fortunately, due to innovative treatments as well as a change in the medical mindset, we are now able to approach cancer therapy with a goal of maximizing quality of life while at the same time controlling disease. In many areas of oncology, especially in advanced, difficult to treat cancers and metastatic disease, the key to pursuing therapy is individualizing treatment to the patient's personal ability to withstand therapy. Thinking of cancer as a chronic disease and gearing therapies to be sustainable and effective is among one of my most important goals as I move forward with our clinical research and cancer treatment programs.


- Listened/answered questions (19)
- Explains conditions well (19)
- Found trustworthy (19)
- View 1 more provider attributes
- Offers Telehealth


- Offers Telehealth

- Listened/answered questions (99)
- Explains conditions well (98)
- Appt. wasn't rushed (96)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (5)
- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- View 2 more provider attributes
- Offers Telehealth
Biography: Rohit K. Jain MD, MPH is an Associate Professor of Medicine at Weill Cornell Medicine and Attending Physician at NewYork-Presbyterian Hospital- Weill Cornell Medical Center. Dr. Jain earned his medical degree at Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, India. He completed Internal Medicine Residency at Johns Hopkins University/Sinai Hospital of Baltimore and Hematology-Oncology Fellowship at Roswell Park Cancer Institute University at Buffalo, New York. After fellowship, Dr. Jain, joined the H. Lee Moffitt Cancer Center in Tampa, Florida as Assistant Professor, and was instrumental in building the bladder cancer program. Dr. Jain was selected as Castle Connolly "Top Doctor" for 2024, as well as one of America's Best Prostate Cancer Oncologist by Newsweek magazine in 2024. Dr. Jain was recruited to Weill Cornell Medicine (WCM) in 2024. He cares for patients with bladder (urothelial), kidney (renal), prostate and testicular cancers, with a major focus in urothelial cancers. His research interests are primarily in urothelial and prostate cancers. Dr. Jain is involved in biomarker research as well as developing innovative clinical trials for patients, and he has received funding from the National Cancer Institute (NCI).

- Offers Telehealth

- Offers Telehealth
